TipRanks
Go Ultimate55% OFF

Tarsus Pharmaceuticals (TARS) Balance Sheet

Tarsus Pharmaceuticals Balance Sheet

Tarsus Pharmaceuticals's total assets for Q2 2026 were $611.14M, an increase of 5.16% from the previous quarter. TARS total liabilities were $264.41M for the fiscal quarter, a 13.88% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 562.16M$ 376.99M$ 265.49M$ 227.86M$ 178.91M
$ 218.73M$ 152.46M$ 68.50M$ 34.96M$ 12.18M
$ 343.43M$ 224.53M$ 196.99M$ 192.90M$ 166.73M

Currency in USD

Tarsus Pharmaceuticals Debt to Assets

0200M400M600M0 %60 %120 %180 %LiabilitiesDebt to Assets20182019202020212022202320242025AssetsLiabilitiesDebt to Assets